Parameters such as chitosan concentration, molecular weight, degree of deacetylation, crosslinker ratio, stirring speed and temperature can be adjusted to tune particle size, surface charge (zeta potential), drug loading efficiency and release kinetics, allowing optimization for specific applications [18, 86]
Imagine you have a battery with 10/20 C ratings
Chugai and Lilly published the preclinical pharmacology data of this molecule together, and Lilly is running Phase III studies on orforglipron for the treatment of Type 2 diabetes and for weight management in adults with obesity or overweight with at least one weight-related medical problem
Non-overlapping targets: vascular and signalling (BPC-157) versus cytoskeletal and migratory (TB-500), reducing redundancy in a stacked protocol
Liraglutide (Victoza, Saxenda)